‘‘(6) NUMBER OF GRANTS.—A political subdivision or a consortium of political subdivisions may not receive more than one grant under paragraph (1).’’; and 

(b) EPIDEMIOLOGY-LABORATORY CAPACITY GRANTS.—Section 2821 (42 U.S.C. 300hh–31) is amended— 

(1) in subsection (a)(1), by inserting ‘‘, including mosquito and other vector-borne diseases,’’ after ‘‘infectious diseases’’; and 

‘‘(iv) a public health emergency due to the incidence or prevalence of a mosquito-borne disease that presents a serious public health threat;’’; and 

(ii) by amending subparagraph (D) to read as fol- lows: 

‘‘(D)(i) is located in a State that has received a grant under subsection (a); or 

‘‘(ii) that demonstrates to the Secretary that the control program is consistent with existing State mosquito control plans or policies, or other applicable State preparedness plans.’’; 

(C) in paragraph (4)(C), by striking ‘‘that extraor- dinary’’ and all that follows through the period at the end and inserting the following: ‘‘that— 

‘‘(i) extraordinary economic conditions in the polit- ical subdivision or consortium of political subdivisions involved justify the waiver; or 

‘‘(ii) the geographical area covered by a political subdivision or consortium for a grant under paragraph (1) has an extreme mosquito control need due to— 

(D) by amending paragraph (6) to read as follows: 

(3) in subsection (f)— 

(A) in paragraph (1) by striking ‘‘for fiscal year 2003, and such sums as may be necessary for each of fiscal years 2004 through 2007’’ and inserting ‘‘for each of fiscal years 2019 through 2023’’; 

(B) in paragraph (2), by striking ‘‘the Public Health Security and Bioterrorism Preparedness and Response Act of 2002’’ and inserting ‘‘this Act and other medical and public health preparedness and response laws’’; and 

(C) in paragraph (3)— 

(i) in the paragraph heading, by striking ‘‘2004’’ and inserting ‘‘2019’’; and 

(I) in clause (ii), by striking ‘‘or’’ at the end; 

(II) in clause (iii), by striking the semicolon at the end and inserting ‘‘, including an emerging infectious mosquito-borne disease that presents a serious public health threat; or’’; and 

(III) by adding at the end the following: 

‘‘(I) the size or density of the potentially impacted human population; 

‘‘(II) the size or density of a mosquito popu- lation that requires heightened control; or 

‘‘(III) the severity of the mosquito-borne dis- ease, such that expected serious adverse health outcomes for the human population justify the waiver.’’; and 

(ii) by striking ‘‘2004,’’ and inserting ‘‘2019,’’. 

